BIOBIJOU Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	29,633	17,130
Revenue Growth (YoY)	72.99%	-
Cost of Revenue	14,815	8,871
Gross Profit	14,819	8,259
Selling, General & Admin	3,982	2,311
Research & Development	1,213	632.7
Other Operating Expenses	47.52	29.74
Operating Expenses	5,592	3,094
Operating Income	9,227	5,165
Interest Expense	-444.24	-594.63
Interest & Investment Income	205.4	126.48
Currency Exchange Gain (Loss)	765.23	400.31
Other Non Operating Income (Expenses)	-922.33	-949.25
EBT Excluding Unusual Items	8,831	4,148
Gain (Loss) on Sale of Investments	148.3	79.14
Gain (Loss) on Sale of Assets	-	0.65
Pretax Income	8,979	4,227
Income Tax Expense	1,791	917.41
Net Income	7,188	3,310
Net Income to Common	7,188	3,310
Net Income Growth	117.16%	-
Shares Outstanding (Basic)	11	11
Shares Outstanding (Diluted)	11	11
Shares Change (YoY)	6.20%	-
EPS (Basic)	630.08	308.13
EPS (Diluted)	630.08	308.13
EPS Growth	104.48%	-
Free Cash Flow	461.05	4,038
Free Cash Flow Per Share	40.41	375.87
Gross Margin	50.01%	48.21%
Operating Margin	31.14%	30.15%
Profit Margin	24.26%	19.32%
Free Cash Flow Margin	1.56%	23.57%
EBITDA	9,927	5,752
EBITDA Margin	33.50%	33.58%
D&A For EBITDA	700.16	587.04
EBIT	9,227	5,165
EBIT Margin	31.14%	30.15%
Effective Tax Rate	19.95%	21.70%
Advertising Expenses	469.22	188.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.